These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 972284)

  • 1. Emergence of gentamicin-resistant bacteria: experience with tobramycin therapy of infections due to gentamicin-resistant organisms.
    Moellering RC; Wennersten C; Kunz LJ
    J Infect Dis; 1976 Aug; 134 Suppl():S40-9. PubMed ID: 972284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M; Taqi-Eddin AR
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical study of tobramycin and gentamicin.
    Klastersky J; Hensgens C; Henri A; Daneau D
    Antimicrob Agents Chemother; 1974 Feb; 5(2):133-8. PubMed ID: 4599859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin resistance in Christchurch hospitals.
    Faoagali JL
    N Z Med J; 1979 Jun; 89(637):426-9. PubMed ID: 381994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin: in vitro and clinical evaluation in 30 patients.
    Perkins RL; Saslaw S; Fass RJ; Prior RB; Scholand JF; Hodges GR; Tight RR; Gardner WG
    Am J Med Sci; 1976; 271(3):297-308. PubMed ID: 820196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.
    Marrie TJ; Gurwith MJ; Ronald AR; Stiver HG; Lank B; Fox L
    Can Med Assoc J; 1977 Jul; 117(2):138-43. PubMed ID: 406032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of gentamicin-resistant gram-negative bacilli in a general hospital.
    Kauffman CA; Ramundo NC; Williams SG; Dey CR; Phair JP; Watanakunakorn C
    Antimicrob Agents Chemother; 1978 Jun; 13(6):918-23. PubMed ID: 677859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriological, clinical, and pharmacological investigations with tobramycin in patients with serious urinary tract infection.
    Iván E; Cstáry KN
    J Infect Dis; 1976 Aug; 134 Suppl():S153-5. PubMed ID: 823274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
    De Rosa F; Tassi C; Stagni GR
    Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247
    [No Abstract]   [Full Text] [Related]  

  • 12. Cross-resistance of Pseudomonas to gentamicin and tobramycin.
    Brusch JL; Barza M; Bergeron MG; Weinstein L
    Antimicrob Agents Chemother; 1972 Mar; 1(3):280-1. PubMed ID: 4625628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of tobramycin, gentamicin, kanamycin, colistin, carbenicillin, and ticarcillin and clinical isolates of Pseudomonas aeruginosa: epidemiological and therapeutic implications.
    Dulong de Rosnay HL; Grimont PA; Dessaut B; Lesgouarres MT
    J Infect Dis; 1976 Aug; 134 Suppl():S50-6. PubMed ID: 823279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal analysis of endemic gentamicin- and tobramycin-resistant gram-negative bacilli in a community hospital.
    Magnussen CR; Jacobson MT
    Infect Control; 1984 Feb; 5(2):88-92. PubMed ID: 6559770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to gentamicin: a growing concern.
    Siebert WT; Moreland NJ; Williams TW
    South Med J; 1977 Mar; 70(3):289-92. PubMed ID: 322294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin-resistant Pseudomonas aeruginosa: Mayo Clinic Experience, 1970-1976.
    Keys TF; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):797-801. PubMed ID: 413012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with tobramycin in the treatment of infections due to gram-negative bacilli.
    Carmalt ED; Cortez LM; Rosenblatt JE
    Am J Med Sci; 1976; 271(3):285-95. PubMed ID: 820195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.